![]() See the Data sources and quality section for more detail. The number of follow up weeks was restricted to 12 to minimise the impact of registration delay, where deaths that occurred in later calendar weeks were less likely to have been registered. However, we used the first six weeks after vaccination as the risk period to ensure that all deaths resulting from myocarditis would be captured. Myocarditis tends to appear very soon after vaccination, with evidence suggesting the median time from vaccination to symptom onset is two days. To assess whether the deaths of young people in 2021 were temporally linked with receiving a COVID-19 vaccination, we compared the number of deaths in two time periods these were weeks one to six following vaccination (risk period) and weeks 7 to 12 following vaccination (baseline period). COVID-19 vaccination and risk of death in young people It is important to investigate potential causes of this excess of death registrations, and consider any possible connection with the vaccination programme. ![]() More deaths were registered in England in 2021 in people aged 15 to 29 years compared with the average for the five years preceding the coronavirus pandemic. Our Deaths registered in England and Wales dataset shows there were around 3,600 such deaths in England each year in the years preceding the coronavirus (COVID-19) pandemic. The overall picture is reassuring, but there are some reports of potential side effects, including an alleged association between vaccination and mild myocarditis and myopericarditis in young people.ĭeaths in people aged 15 to 29 years are relatively rare. An extensive international programme of surveillance and research monitors potential adverse effects. However, the safety of these vaccines is still of concern. The vaccines have had high effectiveness against death and hospitalisation and have saved thousands of lives worldwide. On 8 December 2020, the UK began administering vaccines against SARS-CoV-2 according to the priority groups determined by the Joint Committee on Vaccination and Immunisation (JCVI).
0 Comments
Leave a Reply. |